E
Emil F. Pai
Researcher at University of Toronto
Publications - 203
Citations - 15866
Emil F. Pai is an academic researcher from University of Toronto. The author has contributed to research in topics: Binding site & Xanthine dehydrogenase. The author has an hindex of 58, co-authored 203 publications receiving 14840 citations. Previous affiliations of Emil F. Pai include Toronto General Hospital & University of Georgia.
Papers
More filters
Journal ArticleDOI
Y-700 (1-(3-Cyano-4-(2,2-dimethylpropoxy)phenyl)-1H- pyrazole-4-carboxylic Acid): A Potent Xanthine Oxidoreductase Inhibitor with Hepatic Excretion
Atsushi Fukunari,Ken Okamoto,Takeshi Nishino,Bryan T. Eger,Emil F. Pai,Miho Kamezawa,Ichimaro Yamada,Norihisa Kato +7 more
TL;DR: Y-700 was hardly excreted via the kidneys but was mainly cleared via the liver, suggesting that Y-700 will be a promising candidate for the treatment of hyperuricemia and other diseases in which XOR may be involved
Journal ArticleDOI
Fixed target matrix for femtosecond time-resolved and in situ serial micro-crystallography.
C. Mueller,Alexander Marx,Sascha W. Epp,Yinpeng Zhong,A. Kuo,Aidin R. Balo,Jayashree Soman,Friedrich Schotte,Henrik T. Lemke,Robin L. Owen,Emil F. Pai,Emil F. Pai,Arwen R. Pearson,John S. Olson,Philip A. Anfinrud,Oliver P. Ernst,R. J. Dwayne Miller,R. J. Dwayne Miller,R. J. Dwayne Miller +18 more
TL;DR: The chip concept enables multiple images to be acquired from each crystal, allowing differential detection of changes in diffraction intensities in order to obtain high signal-to-noise and fully exploit the time resolution capabilities of XFELs.
Journal ArticleDOI
Computational design of high-affinity epitope scaffolds by backbone grafting of a linear epitope.
Mihai L. Azoitei,Yih En Andrew Ban,Jean-Philippe Julien,Steve Bryson,Steve Bryson,Alexandria Schroeter,Oleksandr Kalyuzhniy,Justin R. Porter,Justin R. Porter,Yumiko Adachi,David Baker,Emil F. Pai,Emil F. Pai,William R. Schief,William R. Schief +14 more
TL;DR: Backbone grafting of linear motifs is a general method to transplant functional motifs when backbone remodeling of the target scaffold is necessary and bound antibody 2F5 with 30- and 9-fold higher affinity than corresponding side-chain grafting designs.
Journal ArticleDOI
Mechanism of inhibition of xanthine oxidoreductase by allopurinol: crystal structure of reduced bovine milk xanthine oxidoreductase bound with oxipurinol.
TL;DR: The crystal structure of reduced bovine milk xanthine oxidoreductase complexed with oxipurinol was determined and clear electron density was observed between the N2 nitrogen of oxipirinol and themolybdenum atom of the molybdopterin cofactor, indicating that oxipURinol coordinated directly to molyb denum.
Journal ArticleDOI
Activators of Cylindrical Proteases as Antimicrobials: Identification and Development of Small Molecule Activators of ClpP Protease
Elisa Leung,Alessandro Datti,Alessandro Datti,Michele Cossette,Jordan D. Goodreid,Shannon E. McCaw,Michelle Mah,Alina Nakhamchik,Koji Ogata,Majida El Bakkouri,Yi-Qiang Cheng,Shoshana J. Wodak,Bryan T. Eger,Emil F. Pai,Jun Liu,Scott D. Gray-Owen,Robert A. Batey,Walid A. Houry +17 more
TL;DR: The ACP1 chemical structure was considered to have drug-like characteristics and was further optimized to give analogs with bactericidal activity, hence, the ACPs represent classes of compounds that can activate ClpP and that can be developed as potential novel antibiotics.